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Background: The dimorphic fungus Histoplasma capsulatum causes respiratory and systemic disease in mammalian
hosts by expression of factors that enable survival within phagocytic cells of the immune system. Histoplasma’s
dimorphism is distinguished by growth either as avirulent mycelia or as pathogenic yeast. Geographically distinct strains
of Histoplasma differ in their relative virulence in mammalian hosts and in production of and requirement for specific
virulence factors. The close similarity in the genome sequences of these diverse strains suggests that phenotypic variations
result from differences in gene expression rather than gene content. To provide insight into how the transcriptional
program translates into morphological variation and the pathogenic lifestyle, we compared the transcriptional profile of
the pathogenic yeast phase and the non-pathogenic mycelial phase of two clinical isolates of Histoplasma.
Results: To overcome inaccuracies in ab initio genome annotation of the Histoplasma genome, we used RNA-seq
methodology to generate gene structure models based on experimental evidence. Quantitative analyses of the
sequencing reads revealed 6% to 9% of genes are differentially regulated between the two phases. RNA-seq-based mRNA
quantitation was strongly correlated with gene expression levels determined by quantitative RT-PCR. Comparison of the
yeast-phase transcriptomes between strains showed 7.6% of all genes have lineage-specific expression differences
including genes contributing, or potentially related, to pathogenesis. GFP-transcriptional fusions and their introduction
into both strain backgrounds revealed that the difference in transcriptional activity of individual genes reflects both
variations in the cis- and trans-acting factors between Histoplasma strains.
Conclusions: Comparison of the yeast and mycelial transcriptomes highlights genes encoding virulence factors as well as
those involved in protein glycosylation, alternative metabolism, lipid remodeling, and cell wall glycanases that may
contribute to Histoplasma pathogenesis. These studies lay an essential foundation for understanding how gene expression
variations contribute to the strain- and phase-specific virulence differences of Histoplasma.
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Pulmonary infections with the dimorphic fungal pathogen
Histoplasma capsulatum constitute one of the most com-
mon respiratory mycoses, affecting both immunocom-
promised as well as immunocompetent individuals [1,2].
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reproduction in any medium, provided the orwhich are produced by the environmental mycelial form of
the fungus. The dimorphism of Histoplasma is evident
within the mammalian host where the elevated temper-
ature causes differentiation of the conidia into the virulent
yeast form. The yeasts infect, survive, and replicate within
lung alveolar macrophages. The extent of histoplasmosis
disease results from the net contributions of initial inocu-
lum size, the inherent virulence of the strain, and the im-
mune status of the host [3].
The differentiation of Histoplasma into yeasts and ex-
pression of the yeast-phase transcriptional program are
necessary for virulence. Histoplasma cells genetically or
chemically prevented from transitioning into yeast arel Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to the pathogenic phase [4-7]. However, it is most likely
the expression of yeast-phase-specific genes, rather than
the morphology itself, that contributes to Histoplasma
virulence. Accordingly, most Histoplasma virulence fac-
tors identified to date are restricted to pathogenic-phase
yeast cells [8-12].
The H. capsulatum species is constituted of several
geographically and phylogenetically distinct groups. Two
clades, the North American clade 2 (NAm2; e.g., clinical
isolate G217B) and the Panamanian clade (Pan; e.g., clin-
ical isolate G186A) [13,14], typify the diversity among
Histoplasma strains both at the genomic and phenotypic
levels. Both strains are virulent, although in murine models
of histoplasmosis, G217B infection results in higher organ
fungal burdens and increased lethality compared to G186A
[15-17]. The G217B genome is roughly 30% larger than the
G186A genome (41.0 megabases vs. 30.4 megabases, re-
spectively). Most of the excess DNA in G217B is located in
intergenic, repetitive DNA. Both genomes are predicted by
in silico analyses of the genome sequence to encode be-
tween 9,000 and 10,000 genes (http://www.genome.wustl.
edu; http://www.broadinstitute.org). The only differences
in gene content determined to date, are the high-affinity
iron transport genes, FET3 and FTR1, which are found in
the G186A genome but not the G217B genome [18].
The close similarity in gene content and in coding se-
quences among Histoplasma strains suggests that pheno-
typic differences likely result from differences in gene
expression rather than variations in gene content. Two ex-
amples of known virulence factors clearly illustrate this.
First, most Histoplasma lineages, including G186A, have
cell walls containing α-glucan and rely on production of
this polysaccharide for disease establishment [8]. In the
G186A strain, deletion of the α-glucan synthase gene AGS1
causes attenuation due to exposure of immunostimulatory
cell wall β-glucans that are normally masked by α-glucan
[19]. In contrast to G186A, the cell walls of many North
American isolates, represented by G217B, lack α-glucan.
Although G186A and G217B have nearly identical α-glucan
synthase (AGS1) coding sequences, production α-glucan
is absent in G217B during yeast-phase growth. In G217B,
the AGS1 promoter is interrupted by a 2.7-kb insertion of
repetitive DNA elements that alters expression levels of
the synthase. Despite this, G217B remains virulent, sug-
gesting that this strain uses an alternative mechanism to
circumvent the need for α-glucan [15]. The second ex-
ample of expression-based phenotypic differences between
Histoplasma strains is the YPS3 gene, which encodes a
yeast phase specific factor related to the Blastomyces Bad1
protein [20-22]. The genomes of both G186A and G217B
contain the YPS3 gene, but only G217B yeasts produce
the Yps3 protein, which contributes to G217B virulence
[23,24]. Similar to α-glucan, differential production of Yps3appears to result from transcriptional regulation since pla-
cing the YPS3 gene under control of an ectopic promoter
in the G186A background is sufficient to restore Yps3 pro-
tein production [21].
To better understand how gene expression differences
between Histoplasma strains translate into phenotypic
differences including yeast virulence, a more complete
examination of gene expression profiles is needed. Past
technologies for defining the identity and quantity of all
transcripts expressed by an organism have included both
hybridization-based (e.g., microarrays) and sequence-based
(e.g., Sanger sequencing of cDNA or EST libraries) ap-
proaches [25]. Hybridization-based approaches have been
used to study differences in Histoplasma expression be-
tween non-pathogenic (mycelial) phase and pathogenic
(yeast) phases [26,27] as well as during nitrosative stress
[28]. Both of these studies were limited to intra-strain ex-
pression differences. Recently, a microarray-based analysis
of two strains documenting mycelial, yeast, and conidial
gene expression was determined [29]. The analytical power
of microarrays, however, is limited since they are highly
dependent on the accuracy of the predicted gene sets. In-
accurate gene structures derived from ab initio predictions
misses or mispredicts genes resulting in errors in the anno-
tations and subsequent microarray data. In contrast, next-
generation sequencing-based transcriptome determination
defines genes directly from experimentally derived mRNA
sequence evidence. Furthermore, there is no upper limit to
the expression level with the number of mapped reads be-
ing highly correlated to actual gene expression level [25].
In this study, we use next-generation sequencing (i.e.,
RNA-seq) of Histoplasma G186A and G217B yeast and
mycelial mRNAs to profile the respective pathogenic
and non-pathogenic-phase transcriptomes and to iden-
tify interstrain pathogenic-phase expression differences
that may contribute to variations in virulence. Further-
more, we show for a subset of differentially expressed
genes, that differences in expression result from both
cis- and trans-acting factors that affect promoter activity
in the different genetic backgrounds. These findings will
improve our understanding of the mechanisms under-
pinning morphological, biochemical, and virulence dif-
ferences among strains of Histoplasma capsulatum.
Results
Determination of the G186A and G217B Histoplasma
transcriptomes using RNA-seq
To provide an experimental-evidence-based annotation
of the Histoplasma genome, we used RNA-seq method-
ology to construct gene models with transcriptional
support. For a more comprehensive gene definition, we
sequenced the mRNAs from pathogenic-phase (yeast)
and non-pathogenic-phase (mycelia) Histoplasma cells,
the two distinguishing lifestyles of this dimorphic fungal
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Histoplasma (G186A and G217B), representing the Pan
and NAm2 clades, respectively, were analyzed. These two
strains are clinical isolates of Histoplasma, have complete
genome sequences (http://www.genome.wustl.edu; http://
www.broadinstitute.org), and are the two strains for which
molecular genetic methodologies have been established
[8,9,15,30-34]. For yeast-phase RNA samples, strains were
grown to late-exponential phase (approximately 72 hours)
in conditions approximating the mammalian host envi-
ronment (growth at 37°C in 5% CO2 / 95% air). The
growth of two cultures for biological replicate RNA sam-
ples was nearly identical as measured by yeast culture tur-
bidity (data not shown). For mycelia RNA samples, strains
were grown in liquid medium at 25°C in normal air with-
out shaking until sufficient mycelial biomass formed (ap-
proximately 3 weeks). The RNA integrity number (RIN)
[35] for all RNA samples used was ≥ 8.5. Next generation
sequencing (Illumina RNA-seq) of the eight mRNA librar-
ies (two biological replicates for each condition) yielded ap-
proximately 118 million paired-end reads for derivation of
the Histoplasma set of expressed genes (38.6 million and
79.5 million reads for yeasts and mycelia, respectively).
Experimental-evidence-based annotation of the
Histoplasma genome
The transcriptome data was first used to determine gene
structures for G186A as the G186A genome contains
much less repetitive DNA than the G217B genome.
Gene structures were mapped onto the G186A reference
genome by a bioinformatics pipeline that incorporated
reference-genome-based mRNA reads alignment and de
novo transcript assembly (Figure 1). Yeast and mycelia
mRNA reads were aligned to the G186A reference gen-
ome using the spliced alignment tool Tophat [36]. For
yeast, 56.8% of reads (10.8 million) were of sufficient
quality for processing by Tophat analysis, and 84.9% of
these were aligned to the reference genome. For mycelia,
60.9% of reads (20.0 million) were processed with 78.8%
aligning to the reference genome. The exact exon and
intron boundaries were used to inform gene structure
determination through the eukaryotic gene predictor
Augustus [37,38]. Separately, the RNA-seq short reads were
assembled into transcript contigs de novo (i.e., independent
of the reference genome sequence) using Inchworm [39]
and open reading frames extracted from the transcripts
with BestORF (Molquest package, Softberry). The de novo
transcript assembly was input into PASA [40] to refine
the alignment-based gene models with mRNA evidence
(Figure 1). The three data sets were integrated and the
gene models were subjected to a second update with evi-
dence from the de novo transcript assembly reads using
PASA. Lastly, the gene structures were interrogated for
intergenic distances smaller than 500 bp or for intronsgreater than 350 bp based on known Histoplasma gene
and promoter characteristics. These unusual genes struc-
tures were manually refined as appropriate. The final set
of gene structures was annotated for single-copy genes or
for repetitive genes (genes with 2 or more BLAST matches
to the reference genome with e-values < 10-40; designated
with ’R” in the accession number). In addition, genes with
low experimental support (due to very low mRNA cover-
age; FPKM values less than 0.1 in all four libraries, see
below) were identified (designated with “L” in the acces-
sion number). Overall, 9359 gene structures were identi-
fied which included 9026 single-copy genes, 233 repetitive
genes, and 100 genes with low mRNA support.
Due to the high similarity of the genomes of G186A
and G217B and the increased complexity of the G217B
genome from the large amount of repetitive DNA, we
used G186A gene structures to inform construction of
the G217B genes. Short reads in the four G217B mRNA
libraries (2 yeast-phase and 2 mycelial-phase) were aligned
to the G186A reference genome using Tophat with relaxed
parameters to account for the nucleotide variation be-
tween strains. We allowed for 6 mismatches in the 75-bp
G217B short reads, providing at least 92% sequence iden-
tity, which is similar to the identity of known orthologous
genes between strains (identity ranges from 93% to 99%).
Using these parameters, 72% of the processed reads from
each G217B library were matched to the G186A reference
genome with high confidence and these were used to de-
rive the base G217B gene set. As some genes unique to
the G217B genome or only expressed by G217B cells
would be missed, the reference-based alignment and de
novo transcript assembly pipeline (Figure 1) was then ap-
plied to the remaining high quality G217B reads that were
not directly matched to the G186A transcriptome. This
identified an additional 62 G217B genes, which were
added to the G217B models to derive the final G217B gene
set of 9004 genes.
To identify general characteristics of Histoplasma gene
loci, we queried the G186A total gene set for common
features and motifs. The overall gene density in G186A
is approximately 3 genes per 10 kb with an average gene
length of 2041 bp, although there is a very broad range
in exon and gene sizes (Table 1). 77% of genes have at least
one intron. Introns are relatively short in Histoplasma with
a median size of 82 and an average size of 103 base pairs.
We used the defined gene structures in the yeast- and
mycelial-phase transcriptomes to derive a consensus spli-
cing signal. 15 base pairs at both ends of all introns were
extracted and the most frequent 5′ and 3′ splicing signal
motifs determined using the motif finder MEME [41]. The
consensus splicing signals were GTA[A/T]G at the 5′ end
of the intron (Figure 2A) and [C/T]AG at the 3′ end of
the intron (Figure 2B), consistent with the intron 5′ GT
and 3′ AG of eukaryotic splicing mechanisms [42].
RNA-seq
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     9026 single copy genes
     233 repetitive copy genes (“R” genes)
     100 genes with low experimental support (“L” genes) 
Figure 1 Transcriptional evidence-based pipeline for assembly of Histoplasma G186A gene models. RNA-seq data was used to generate
spliced alignment models to the reference genome (gene set 1 and 2) as well as de novo assembly into contiguous transcripts (gene set 3′).
Gene sets 1 and 2 were updated by PASA (red triangles) using the de novo transcript assembly. The three gene sets were integrated and
subjected to an additional update using the de novo mRNA assembly. The resultant gene set was manually refined after inspection of the
models for genes with unusual characteristics (introns greater than 350 bp or intergenic distances less than 500 bp). The final gene models were
subsequently categorized as single copy genes, repetitive genes, or genes with low experimental support (gene models based on low numbers
of RNA-seq reads).
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To determine the improvement in accuracy of the gene
definitions resulting from RNA-seq, we compared our
G186A gene models with the current ab initio G186A
gene predictions (http://www.broadinstitute.org/annota
tion/genome/histoplasma-_capsulatum/MultiHome.html).
Transcriptome sequencing yielded 126 more genes. The
total length of exon regions from RNA-seq is 17.3 Mb
(56.7% of the genome), compared with 13.8 Mb (45.2% of
the genome) in the ab initio predictions. To further com-
pare the sensitivity of the gene definitions from RNA-seqTable 1 G186A gene statistics
Average Middle 90% range
Gene length (bp) 2041 333 - 4857
Exons per gene 3.0 1 - 7
Exon length (bp) 587 39-2103
Introns per gene 2.6 1 - 6
Intron length (bp) 104 54 - 237
Gene density (per kb) 3.1 N/Awith the ab initio gene models, we analyzed where mRNA
reads aligned in the respective gene models (RNA-seq
based or ab initio predictions). A read with > 95% of its
length aligning to a region defined as an exon was consid-
ered as strong experimental validation of the locus. By these
strict criteria, 72% of the G186A mRNA reads matched the
RNA-seq-derived gene structures (Figure 3A). In contrast,
only 54% of the mRNA reads matched the ab initio gene
predictions. A similar proportion of reads aligned to intron
regions in both data sets (0.47% and 1% for RNA-seq and
ab initio gene models, respectively). Reads aligning to in-
tronic or overlapping multiple region classifications are not
unexpected due to partially processed RNAs in the tran-
scriptome library and the possibility of alternative splicing
events [36]. This indicates the mRNA evidence more
strongly supports the RNA-seq-derived gene set compared
to the ab initio gene predictions. In addition, there are not-
able differences in the introns defined in the RNA-seq
based gene structures and the ab initio predictions. The
RNA-seq data shows 90% of introns are between 54 and
237 bp in size (Table 1). The ab initio predictions are
slightly broader with the middle 90% ranging from 51 to
nn-
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Figure 2 Derived consensus of intron splicing signals. The intron sequences common to the intron 5′ end (A) and the intron 3′ end (B) of
Histoplasma genes. The vertical height of the nucleotide at each position indicates the relative nucleotide frequency (y-axis).
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introns have an overall range from 11 to 1566 bp in size,
which includes 1597 introns larger than 300 bp in size.
These longer and shorter intron sizes in the ab initio pre-
dictions are not supported by the mRNA reads suggesting
prediction errors in the ab initio exon-intron definitions.
These data indicate that the RNA-seq-based annotation
greatly improves the accuracy of exon boundaries and over-
all gene definitions.
To determine the false positive rate, we also compared
the exon structure accuracy by calculating the exon
coverage rate by mRNA short reads (Figure 3B). An
exon with 99% or more coverage was defined as perfect
support, 70-99% coverage as fair support, and less than
70% coverage as poor support. 95.2% of exons defined
by our optimized gene model pipeline show perfect sup-
port by mRNA short reads, compared to 89.8% of exons
defined by in the ab initio predictions. Only 0.8% of
exons in our gene models had poor support compared
to 2.8% of exons in the in ab initio gene prediction set.
Thus, the gene models derived from our optimized pipe-
line are more supported by experimental evidence and
thus have more accurate structures.
As further validation of the gene structures defined by
RNA-seq, we sequenced the mRNAs for some genes
with discrepant structures between the RNA-seq-derived
gene set and the ab initio predictions (Figure 3C-E). For
each selected gene, a cDNA spanning all exons was gen-
erated by RT-PCR and the amplicon was sequenced to
provide nucleotide-level validation of the gene structure.
We resolved differences in gene structure predictions for
theMFS5 gene, which encodes a predicted major facilitator
superfamily membrane transporter and two hypothetical
genes (i.e., genes without recognizable functions), HYP12
and HYP13. The sequence of the MFS5 cDNA shows the
MFS5 gene is composed of 6 exons, which completelymatches the RNA-seq-derived structure (Figure 3C). The
ab inito MFS5 gene prediction has 5 exons, inaccurately
missing the intron between exons 2 and 3. For the HYP12
gene, 5 exons were correctly defined by RNA-seq, but the
ab initio predictions missed exon 2, instead including an
abnormally large 451 base-pair intron (Figure 3D). For the
HYP13 gene, RNA-seq accurately defined the gene with 2
exons whereas ab initio mispredicted the location of the
second exon and added a third exon further downstream
(Figure 3E). Together, these data demonstrate the greater
experimental support and the improved accuracy in gene
structure definition from the RNA-seq based transcrip-
tome compared to the ab initio predicted gene models.
Quantitative gene expression profiling
The transcription profile and relative gene expression levels
for genes expressed by G186A and G217B Histoplasma
cells were determined by counting the number of matching
RNA-seq reads from each strain. Relative expression
levels were calculated using the Cufflinks algorithm [43].
To enable cross-species and cross-phase comparisons,
gene expression levels were normalized and calculated as
Fragments Per Kilobase of exon per Million fragments
mapped (FPKM; [44]). Analysis of the FPKM values for the
biological replicates of each phase for each Histoplasma
strain shows the replicates are highly similar (Additional
file 1: Figure S1). Thus, the mean FPKM between replicate
libraries was used for calculation of the fold change in gene
expression levels.
General features of the gene expression levels for each
strain and phase are presented in Table 2. The mean gene
FPKMs for yeast and mycelia libraries was compared to
determine the degree to which genes are differentially reg-
ulated between yeast and mycelial phases (Figure 4). A 5-
fold difference in FPKM values was used as a conservative
criterion for significant differential expression. In G186A,
ab initio gene model
D. HYP12












































Figure 3 (See legend on next page.)
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Figure 3 Comparison of RNA-seq-derived gene models with Histoplasma ab initio gene predictions. The accuracy of the RNA-seq-derived and
ab initio gene models for G186A were measured as the frequency of mRNA reads that match the modeled gene structures (A), the percentage of
exon structures with mRNA experimental support (B), and direct sequencing of mRNAs (C-E). (A) Percentages indicate the number of cDNA library
reads that match to exons (blue), introns (red), intergenic regions (green), or spanning multiple regions (yellow) in the RNA-seq-derived or ab initio
gene set models. (B) Accuracy of the exon definition is indicated by the percentage of exons with perfect support (blue; at least 99% of the exon
length is covered by mRNA reads), fair support (red; 70% to 99% of the exon length is covered by mRNA reads), or poor support (green; less than 70%
of the exon length is covered by mRNA reads). (C-E) Schematics of gene structures are shown as exons (horizontal boxes below the x-axis) for
RNA-seq-derived models (red) and the ab initio predictions (blue). The horizontal represents the genome sequence in that interval. Vertical histogram
(grey bars) depicts the frequency of mRNA reads that match that particular region of the genome sequence. Models are depicted for the MFS5 gene
(C) that encodes an MFS-family transporter, the HYP12 gene (D) and the HYP13 gene (E), two genes encoding factors of unknown function.
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genes upregulated in yeasts and 217 genes upregulated in
mycelia; Figure 4A). G217B gene expression analysis shows
a similar trend: 751 genes are differentially expressed with
423 genes upregulated in yeasts and 328 genes upregulated
in mycelia; Figure 4B). Overall, 6% to 9% of Histoplasma
genes show phase-dependent expression. Gene expression
data for G186A and G217B are presented in Additional file
2: Table S1 and Additional file 3: Table S2, respectively.
Examination of genes whose expression is upregulated
in the yeast phase highlights features potentially linked
to the virulence that characterizes this phase. The set of
upregulated yeast-phase genes includes CBP1, SOD3,
CATB, CFP4, CFP8, ENG1, TRL1, all well established
yeast-phase expressed genes in both strains [31,45], many
of which have been linked to virulence [9,10,12]. Consis-
tently, CBP1 is one of the most highly expressed genes
(FPKM values at least 8000) and one of the most differen-
tially expressed (at least 1000-fold increased expression
in yeast compared to mycelia). The virulence-promoting
AGS1 and YPS3 genes are also enriched in yeast, but only
in G186A and G217B, respectively.
The list of genes with significant yeast-phase enriched
expression (at least 5-fold compared to mycelia) is pre-
sented in Additional file 4: Table S3. In total 275 genes
were upregulated in yeasts with 43 genes upregulated in
both strains (100 were upregulated only in G186A yeasts
compared to G186A mycelia and 132 were upregulated
only in G217B yeasts compared to G217B mycelia). In
G186A, the most differentially expressed gene is HC186_
02213 (1735-fold induced in yeast), a gene of unknown
function. In G217B, the gene most upregulated in yeast
is CBP1. In both strains, the GNT1 gene, which encodes
an N-acetylglucosaminyltransferase involved in N-linkedTable 2 G186A and G217B gene expression statistics
Yeast Mycelia
G186A G217B G186A G217B
FPKM range 0 – 13514 0 – 15819 0 – 6727 0 – 17942
FPKM median 28 27 25 21
Genes comprising 50%
of total transcripts
870 737 671 360protein glycosylation, is consistently highly upregulated
(53-fold and 78-fold in G186A and G217B, respectively).
G217B yeasts also upregulate an α-mannosyltransferase
(MNN2; 104-fold).
Genes upregulated in yeasts compared to mycelia sug-
gests different metabolism between the phases. Genes en-
coding enzymes involved in coenzyme A (CoA) synthesis
(2-dehydropantoate 2-reductase (PAN5) and pantetheine-
phosphate adenylyltransferase (CAB4)) are also signifi-
cantly upregulated in yeasts despite pantothenate in the
growth medium. Various membrane transporters are also
more highly expressed in yeasts compared to mycelia in-
cludingMFS- and ABC-type transporters and proteins pu-
tatively transporting metabolites such as amino acids (3
transporters including the general amino acid permease
GAP1), zinc (a zinc transporter in G186A yeasts and
ZRT2 in G217B yeasts), sulfate, and phosphate. Yeasts of
both strains also upregulate the ATG1 kinase.
Yeasts are also characterized by increased expression of
various transcriptional control proteins, which may under-
lie the differing expression profiles of yeasts and mycelia.
In G186A and G217B, a subunit of TFIIE (encoded by an
ortholog of TFA2) is upregulated 32-fold and 73-fold, re-
spectively. G186A yeasts and G217B yeasts compared to
their respective mycelia also have higher expression of
Zn-finger transcription factors (two in G186A and one in
G217B). Both strains upregulate expression of the gene
encoding a subunit of DNA Polymerase II, which may in-
dicate a greater DNA synthesis capacity, is required for
faster cell cycles in yeast compared to mycelia.
Although a few inferences can be made from the yeast-
phase regulon, the vast majority of yeast-phase regulated
genes (80% of G186A and 73% of G217B) encode hypo-
thetical proteins with no ortholog with known biochem-
ical or molecular function. This highlights how little is
currently understood about the gene expression profiles
that provide for a pathogenic lifestyle compared to non-
pathogenic growth.
Identification of strain-specific, pathogenic-phase gene
expression profiles
To discover genes that potentially contribute to viru-
lence differences between strains, we compared the

















































5-fold increased expression in mycelia
5-fold increased expression in yeast
similar expression
Figure 4 Identification of G186A and G217B genes with enriched expression in the two different morphological phases. FPKM values
were used to compare the gene expression levels between the yeast-phase and the mycelial-phase of G186A (A) or G217B (B) Histoplasma. Data
points represent the log2 transformation of the FPKM value for individual gene expression in yeasts (x-axis) and mycelia (y-axis). Colors represent
genes without significant phase-dependent regulation (blue; genes showing less than 5-fold change in expression), genes with increased
expression in yeast-phase Histoplasma (purple), and genes with increased expression in mycelial-phase Histoplasma (orange).
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of G186A and G217B. Differential gene expression by
pathogenic phase yeasts includes (1) genes with higher ex-
pression in one strain (at least 5-fold difference in FPKM
ratio), (2) genes only expressed by one strain (FPKM of 0
in the other strain), and (3) genes structurally unique to
the genome of one strain (genes with no BLAST match to
the genome of the other strain with an e-value less than
10-35 and covering 50% of the query gene). With inclusion
of the uniquely expressed and the structurally unique
genes between strains, 8978 genes in total were compared
and genes with at least 5-fold differential regulation be-
tween strains identified (Figure 5A). To avoid overesti-
mation of the fold change between backgrounds, genes
with low levels of yeast phase expression (FPKM less than
0.5 in both strains) were excluded as the magnitude of the
ratio of their expression ratios was unreliably magnified by
low FPKM values. 100 genes overall were excluded due
to low FPKM values. From this analysis, we identified 442
G186A-specific genes (279 upregulated genes and 163
structurally unique genes) and 241 G217B-specific genes
(190 upregulated genes and 51 structurally unique genes)
(Figure 5B).
To identify the possible functions of the gene products of
differentially expressed yeast-phase genes, protein homolo-
gies were assigned based on BLAST, Gene Ontology (GO)
terms and the Kyoto Encyclopedia of Genes and Genomes(KEGG). Histoplasma gene products were categorized into
sixteen general functional classes or were designated as
“hypothetical” if no functional homology or definition could
be made (Figure 6). Upregulated yeast-phase genes in
G186A showed enrichments (P-value < 0.05) in 15 different
classifications (Figure 6A), G217B yeast-phase upregulated
genes included 17 different classifications (Figure 6B). For
the majority of lineage-enriched genes, no specific function
could be assigned based on the amino acid sequence. As a
class, genes encoding kinase/phosphatase functions as well
as membrane transport proteins are enriched in G186A
yeasts compared to G217B yeasts. For G217B, genes encod-
ing factors for glycan metabolism, oxidoreductases, and
functions linked to mitosis and cell cycle progression are
enriched in G217B yeasts compared to G186A yeasts. Both
strains have similar number of genes encoding amino acid,
carbon, and lipid metabolism, although the specific gene
products in these categories differ between the strains.
The complete list of genes unique to G186A or with
enhanced expression in G186A is detailed in Additional
file 5: Table S4. Genes structurally unique to G186A or
only expressed by G186A yeasts comprise most of
the enriched kinase/phosphatase functions but also in-
clude FET3, FTR1, an ARN-family siderophore trans-
porter (ARN2), and a predicted quinone oxidoreductase
(ZTA1). Among the genes with enriched expression in







































Figure 5 Yeast-phase expressed genes with lineage-specific gene
expression differences. Expression levels of individual genes in G186A
and G217B were compared using FPKM values for yeast-phase cells.
(A) Data points represent the log2 transformation of the expression
(FPKM) of individual genes in G186A yeasts (x-axis) and G271B yeasts
(y-axis). Data point color indicates genes with similar expression levels in
G186A compared to G217B (blue; less than 5-fold change), genes with
significantly increased expression in G186A yeast (green; at least 5-fold),
or genes with significantly increased expression in G217B yeast (red; at
least 5-fold). Data points clustering at log2(FPKM) =−3.32 represent genes
whose expression was FPKM< 0.1, which were then set to (FPKM=
0.1) as the lowest reasonable limit of detection. (B) Venn Diagram of
lineage-specific gene expression: genes not differentially expressed (blue
overlap) or genes with increased expression (at least 5-fold) in G186A
yeast (green) or in G217B yeast (red). Genes with strain-specific
expression were further divided into those that were structurally unique
to the G186A or G217B genome (unique) or orthologous genes that
were differentially expressed by G186A and G217B yeasts (enriched).
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http://www.biomedcentral.com/1471-2164/14/695glycosyl transferase (ATG26) and a chitinase (CHI1), two
phospholipases (PLB1 and PLD1), a glyoxylate reductase
(GOR1), and an N-acetyltransferase (ARD1).
In contrast, G217B yeast has unique or enriched ex-
pression of a different set of genes that are detailed in
Additional file 6: Table S5. Expressed genes unique tothe G217B genome, and for which clear orthologous
proteins could be identified, encode a putative beta-
glucanase (TOS1) and two kinases potentially involved
in cellular signaling (PKH2 and GSK3). A v-SNARE pro-
tein is also uniquely encoded in the G217B genome by
the YKT6 gene, which may indicate differential traffick-
ing of vesicles in this strain. Genes of the siderophore
biosynthesis gene cluster (i.e., SID3, SID4, OXR1, MFS1,
and NPS1); [46] are preferentially expressed by G217B
yeasts compared to G186A yeasts even though both ge-
nomes have this cluster. Interestingly, genes encoding
histones (H1, H2A, H2B, H3, and H4) all show increased
expression in G217B yeasts. Genes encoding a copper
transporter (CTR3) and one of three carbonic anhydrases
(CAH1) are 68-fold and 30-fold more expressed, respec-
tively, in G217B than G186A. The genes for a ras-GTPase
activating protein (IQG1), a MAP kinase kinase kinase
(SSK2), a Ca2+/calcineurin-dependent transcription factor
(CRZ1), and a histone deactylase (HOS1) show increased
expression in G217B. G217B-enriched genes also include
factors linked to Histoplasma virulence, namely Yps3
(nearly 300-fold), but also the secreted superoxide dis-
mutase (Sod3; [10]) and the secreted catalase (CatB; [12]).
To validate the pathogenic-phase gene expression dif-
ferences between strains, we used quantitative RT-PCR
as an independent determination of yeast gene mRNA
levels. Accurate quantification between strains requires
normalization to genes whose expression does not sig-
nificantly vary between strain backgrounds. A number of
housekeeping genes have been used in intraspecies ex-
pression quantifications, but few have addressed the
appropriate normalizer for interspecies comparisons. To
identify genes with minimal variation between strains, we
examined a set of constitutively expressed and housekeep-
ing genes representing translation (ribosomal subunit and
translation elongation factors; RPS1B, TEF1, and TEF3),
metabolism (glyceraldehyde-3-phosphate dehydrogenase;
TDH1), the cytoskeleton (actin; ACT1), and yeast-phase
growth (CBP1) and determined the degree of co-variation
with each other between strains. The relative expression of
each gene was computed using the ΔΔCT method [47]
after normalization to each one of the other genes. As an
indicator of overall transcriptional discrepancy among
these genes, the magnitudes of the ΔΔCT values obtained
were summed and the normalizing gene that produced the
greatest amount of overall interstrain variation was identi-
fied (Figure 7A). This process was repeated iteratively after
excluding this normalizing factor from subsequent calcula-
tion until no significant change in the total variation was
reached by further normalizing gene exclusion. Through
this analysis, we determined that CBP1 and ACT1 were
more variable than desired between strains and therefore
unsuitable as normalizing factors, and that TEF1, TEF3,
TDH1, and RPS1B were expressed at sufficiently similar
A. G186A
B. G217B
1. amino acid transport and metabolism
12. mitosis and cell cycle
9. co-factor and nucleotide processing
7. kinase / phosphatase
5. lipid / fatty acid metabolism
4. iron metabolism
3. glycan metabolism
13. genetic information processing







































Figure 6 Functional classification of G186A- and G217B- enriched genes. Chart depicts the proportion of genes that show increased
expression in G186A (A) or G217B (B) by the putative functional class of the encoded gene product. Genes encoding factors with no identifiable
function based on protein sequence homology were categorized as “hypothetical.”
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http://www.biomedcentral.com/1471-2164/14/695levels between strains to be used as normalizing genes for
quantitative RT-PCR (Figure 7A). The TEF3 gene was se-
lected for normalization of relative expression levels.
Quantitative RT-PCR was used to confirm the expression
differences between strains for a subset of 41 differentially
expressed and similarly expressed genes. Both genes
encoding proteins with recognizable functions as well
as genes without known functions (HYP genes) were
included. In addition the CBP1, SOD3, CATB, and YPS3
genes were included to determine if expression differ-
ences in these known virulence factors [9,10,12,23] cor-
related with differences in strain virulence. The relative
fold-change in expression between strains determined
by FPKM analysis was highly correlated with differences
determined by qRT-PCR (R2 = 0.88; Figure 7B) providing
validation of the FPKM analysis. Genes significantly more
expressed by G186A included HYP18 (234.5-fold), ENV9(68.0-fold), a putative alkaline phosphatase (PHO1; 43.9-
fold), MFS5 (39.2-fold), HYP8 (11.0-fold), TRL1 (10.6-
fold), HYP7 (9.8-fold), SNF3 (9.6-fold), HYP17 (9.4-fold),
ACS1 (8.2-fold), HYP3 (6.9-fold), and KIN2 (4.9-fold).
Genes significantly more expressed by G217B included
YPS3 (1019.3-fold), HYP16 (58.4-fold), HYP15 (34.4-fold),
HYP1 (23.4-fold), SID4 (17.4-fold), H2B (16.0-fold), CAH1
(15.7-fold), SOD3 (15.7-fold), CTR3 (13.9-fold), OXR1
(12.3-fold),HYP10 (7.8-fold), andCATB (6-fold) (Figure 7C).
Regarding known virulence factors,YPS3, SOD3, and CATB
were more highly expressed by G217B while CBP1 was
slightly more expressed in G186A.
Factors determining inter-strain variation in expression
of genes
Differential gene expression is often regulated at the



































































































































































































































































Figure 7 (See legend on next page.)
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Figure 7 Validation of FPKM-based gene expression by quantitative RT-PCR. (A) Identification of genes with minimal variation in expression
between strains. Gene expression of candidate normalization genes (TEF1, TEF3, RPS1B, TDH1, ACT1, and CBP1) was determined by qRT-PCR. Expression
values were normalized to one member of the gene set and the total difference in cycle threshold between strains (y-axis) determined for the
remaining genes. Colors correspond to which gene was used for normalization and the resultant total variation in cycle thresholds. The process was
repeated iteratively by removing the gene, which when used as the normalizer, resulted in the greatest overall difference in expression between
strains. Included genes are listed under the x-axis. Horizontal bars represent averages. Significantly different total cycle threshold variations determined
by Student’s t-test are indicated (*, P < 0.5; **, P < 0.1; ns, non-significant). (B) Correlation between FPKM and qRT-PCR determination of gene
expression between G186A and G217B yeasts. Data points represent the log2-transformed value of the fold-change in expression determined by
qRT-PCR after normalization to TEF3 (x-axis) or by FPKM ratio (y-axis). Data point color indicates genes with no difference in expression (black; < 5-fold),
genes upregulated in G186A (green; > 5-fold), and genes upregulated in G217B (red, > 5-fold). Error bars represent the standard deviation of the
relative expression of three replicate yeast cultures for each strain. (C) Relative expression of selected genes in G186A yeasts compared to G217B
yeasts. Bars represent the average fold change (log2) and error bars represent the standard deviation (n = 3 for each strain). Analyzed genes (x-axis)
and data are colored to indicate genes with no enriched expression in either strain (black), genes upregulated in G186A yeasts (green; > 5-fold), and
genes upregulated in G217B yeasts (red; > 5-fold). Asterisks denote genes with established roles in Histoplasma yeast virulence.
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http://www.biomedcentral.com/1471-2164/14/695trans-acting regulatory factors. To determine if cis- or
trans-acting factor differences between strains determine
Histoplasma interstrain gene expression variability, we
created transcriptional reporter fusions using putative
promoter regions upstream of differentially expressed
genes and transformed them into the G186A and G217B
backgrounds. Promoter regions (0.6 to 2 kb of sequence
upstream of the CDS) for TEF1, CTR3, SOD3, AGS1,
YPS3, MFS5 and ENV9 from both G186A and G217B
were fused to a gfp reporter gene. To test if cis-acting
factors (e.g., promoter sequence polymorphisms between
strains) or trans-acting factors (e.g., transcription factors
differences) controlled the differential transcription, pro-
moter fusions for each of the G186A and G217B promoters
were transformed into both the G186A-background. The
level of GFP fluorescence in transformed colonies was used
as a surrogate measure of gene expression levels. Consistent
with the RNA-seq and qRT-PCR analyses, TEF1 promoter
fusions to gfp yielded similar fluorescence regardless of the
strain from which the promoter was derived or the back-
ground into which it was placed (Figure 8A). Therefore the
fluorescence of the TEF1 promoter fusions were used to
normalize exposure times for GFP fluorescence between
backgrounds for the other promoter tests.
For genes more highly expressed in G217B, we tested
whether the promoter sequence was responsible for the
variation in gene expression. Three genes more highly
expressed in G217B were selected for investigation: CTR3,
SOD3, and YPS3. For CTR3, 1.45 kb of upstream se-
quence was sufficient to cause expression of the gfp
reporter (Figure 8B). The CTR3 promoter nucleotide se-
quences are 92% identical between G217B and G186A.
GFP reporter fluorescence was significantly higher in
the G217B background (2.1 to 2.9-fold) regardless of the
strain from which the promoter sequence originated.
This indicates that the enhanced expression of CTR3 in
G217B is independent of polymorphisms in the pro-
moter but highly dependent on the genetic background
(i.e., trans-acting factors that differ between the strains).In contrast to CTR3, cis-acting factors (i.e., promoter
sequences) are the major determinants of interstrain ex-
pression differences for SOD3 and YPS3. The G217B se-
quence of the SOD3 promoter (1.9 kb) provided higher
transcription of the GFP reporter than the G186A SOD3
promoter in both strain backgrounds (1.8-fold and 1.9-
fold; Figure 8C). For regulation of YPS3 expression, the
G186A sequence of the YPS3 promoter (1.9 kb of upstream
sequence) could not drive transcription of the GFP reporter
in either strain background whereas the G217B sequence of
the promoter enabled transcription of the reporter gene
(Figure 8D). Thus, transcription of YPS3 is controlled pri-
marily by the promoter sequence, although transcription of
the reporter was 2.4-fold higher in the G217B background
than the G186A background suggesting the contribution of
some additional trans-acting factors operating in G217B.
To determine whether cis- or trans-acting factors deter-
mined expression differences of genes more highly ex-
pressed in G186A, promoter fusions were created using
sequences upstream of the AGS1 (1.9 kb), MFS5 (1.9 kb),
and ENV9 (1.9 kb) genes. Previously we showed that
AGS1 transcription was significantly attenuated in G217B
due to insertional disruption of the promoter [15] indi-
cating cis-control of AGS1. Removal of the disrupting
sequences from the G217B AGS1 promoter restored tran-
scriptional activity in both G186A and G217B back-
grounds indicating deficient AGS1 expression in G217B
is primarily due to the disruption in the promoter
(Figure 8E). For MFS5 promoter-gfp fusions, transcription
of the reporter gene was strongly influenced by the strain
background with both G186A and G217B MFS5 promoter
sequences driving 2.0-fold to 3.0-fold more transcription in
the G186A background (Figure 8F). Thus, MFS5 transcrip-
tional differences arise predominantly from differences in
the strain background rather than promoter polymor-
phisms. Transcriptional gfp fusions to the ENV9 promoter
(up to 1.9 kb) failed to produce any GFP fluorescence in
transformants irrespective of the genetic background or
which promoter sequence was used. We suspect that the







































































































































































































































































































Figure 8 (See legend on next page.)
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Figure 8 Regulation of differentially expressed genes by cis- or trans-acting factors. Promoters of genes differentially expressed in G186A
and G217B yeasts were fused to a gfp reporter and transformed into both strain backgrounds. Promoter regions (“P”) were amplified from G186A
or G217B genomic DNA and the constructs transformed into Histoplasma yeasts. Expression of the gfp reporter was measured in transformants by
quantifying GFP fluorescence (A-G) or by qRT-PCR measurement of gfp mRNA (H). (A) Representative images of GFP fluorescence of individual
transformants in which gfp expression was driven by the G186A and G217B TEF1 promoters (PTEF1) in the G186A (green) or G217B (red)
background. (B-H) Data represents the GFP fluorescence from individual transcriptional-reporter gene fusion transformants in the G186A
background (green data points) and the G217B background (red data points). Data is normalized to gfp expression driven by the TEF1 promoter
to enable interspecies comparisons. Dashed horizontal lines indicate the autofluorescence of G186A and G217B yeasts lacking the gfp reporter
(“none”). Reporter gene expression driven by the TEF1 promoter (B), the CTR3 promoter (C), the SOD3 promoter (D), the YPS3 promoter (E), the
AGS1 promoter (F), the MFS5 promoter (G), and the ENV9 (H) was measured. The AGS1 promoter from G217B was repaired by removal of the
inserted repetitive DNA for comparison to the native G186A promoter. Horizontal bars represent means ± standard deviations (n≥ 22 (A-G) or 3
pools of 3 replicates each in (H)). Significant differences in expression between the G186A and G217B genetic backgrounds were determined by
Student’s t-test and are indicated by asterisks over the G217B transformant data (*, P < 0.05; **, P < 0.01, ***; P < 0.001; ns, non-significant).
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http://www.biomedcentral.com/1471-2164/14/695lack of GFP protein production results from unknown al-
ternative translational start sites, which could shift gfp
translation out of frame. As an alternative means of test-
ing for transcriptional activity of the different ENV9 pro-
moters without requiring reporter protein synthesis, we
used quantitative RT-PCR of the gfp transgene. For ENV9,
both the promoter and background influenced the expres-
sion of the transgene with increased expression driven by
the G186A promoter. This indicates that ENV9 expression
is strongly influenced by promoter sequence, but the stron-
gest expression was in the G186A background indicating
trans-acting factors also contribute to ENV9 expression
differences (Figure 8G). Together, these data provide ex-
amples that show gene expression differences among
Histoplasma strains that are determined by cis acting
factors (i.e., promoter sequence) and/or variations in
trans acting factors (e.g., translation factor abundance
or activity) that exist between strain backgrounds.
Discussion
While genome sequencing provides an excellent starting
point for characterization and analysis of Histoplasma
capsulatum’s nearly 10,000 genes, accurate gene struc-
ture determination requires experimental evidence. Use
of tiling microarrays with isolated RNAs improved gene
structure definition in Histoplasma [27]. In this study, we
used RNA-seq to inform gene models for two Histoplasma
clinical isolates, G186A and G217B, representing divergent
phylogenetic clades. In addition to spliced-alignment of the
mRNAs to a references genome, we used de novo assembly
of the mRNAs at multiple points of the annotation pipeline
to further refine annotations with experimental evidence.
The assembled mRNA sequences generated more precise
gene models than those derived from ab initio predictions,
and improved the evidence-based resolution of the gene
structures to the nucleotide level.
In addition, RNA-seq enabled a comparative gene ex-
pression approach to identify phase-specific as well as
strain-specific gene profiles. As Histoplasma cells exist asyeasts during mammalian infection, we directed our efforts
at identification of genes preferentially expressed by these
virulent cells compared to mycelia that are unable to es-
tablish disease. Overall, we found that 6% to 9% of the gen-
ome is differentially expressed between these two phases.
Microarray-based studies found 5% [26] to 19% [29] of
genes had phase-dependent regulation. The dramatically
increased percentage of regulated genes in Inglis et al.,
likely results from the 3-fold differential expression criteria
they used, whereas we required a more stringent threshold
of 5-fold differential expression. By RNA-seq, we found
that growth as yeast cells results in induced expression of
3% to 5% of the genes. Assuming that increased expression
confers the characteristics required for pathogenic-phase
growth, 300 to 400 genes could potentially contribute to
Histoplasma virulence.
Genes preferentially expressed by yeast-phase cells of
both strains suggest some functions that characterize
pathogenic-phase growth. Yeast cells upregulate gene ex-
pression of enzymes for glycosylation of proteins (Gnt1 and
an α-mannosyltransferase). These yeast-phase-expressed
glycoysltransferases suggest that yeasts, but not mycelia,
rely upon glycosylation of extracellular proteins as they
transit through the ER and Golgi. In support of this,
Holbrook et al. found that proteins from yeast culture fil-
trates, but not mycelia culture filtrates, are heavily glyco-
sylated [45]. Yeast cells also upregulate enzymes involved in
CoA synthesis (e.g., Pan5 and Cab4) that may indicate yeast
have additional CoA/acetyl-CoA need for carbon and lipid
metabolism pathways. Yeast cells have increased expression
of ATG1, a kinase that is involved in regulating autophagy
in response to environmental signals [48-50]. As the cDNA
libraries were prepared from yeasts and mycelia grown
in identical growth medium, the yeast-phase upregulated
genes presumably represent gene expressions regulated by
lifestyle rather than nutrient availability.
The phylogenetic groups represented by G186A and
G217B strains are notably dissimilar in many of the
yeast-phase-enriched genes. Only 43 of the 275 genes
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common between the two strains. This may not be sur-
prising as G186A and G217B have been shown to have dif-
ferent relative virulence in murine models [15-17] and
utilize different virulence factors to mediate their patho-
genesis [15,19,23]. Gene expression differences between
strains indicate that the different Histoplasma lineages are
more dissimilar than previously assumed. For example, ex-
pression of a high affinity copper transporter (CTR3) and a
carbonic anhydrase (CAH1) are substantially increased in
G217B while an MFS-family transporter (MFS5) shows
100-fold more expression in G186A. Our data indicate
that the differential regulation of genes between strains re-
sults from differences in cis-acting sequence polymor-
phisms in the promoter of genes as well as trans-acting
factors that reflect the different background of the strains.
Our expression profiling highlights differences in iron
acquisition between G186A and G217B. We found that
the SID1 gene, which is involved in siderophore synthesis,
is only yeast-phase enriched in G217B contrary to the
microarray analysis [29]. Both G186A and G217B express
ARN-family siderophore transporters. In G217B, one fam-
ily member has enriched expression in yeasts compared
to mycelia. On the other hand, G186A yeasts express an
ARN-family transporter unique to the G186A genome
and the G186A-specific iron oxidase and permease encod-
ing genes FET3 and FTR1. This data indicates G217B and
G186A differ in the mechanisms for iron acquisition.
The G186A-enriched gene set suggests G186A yeasts
differ from G217B yeasts in lipid metabolism. G186A
has increased expression of two phospholipases, Plb1 and
Pld1, as well as the acyl chain desaturase Ole1, which has
been linked to Histoplasma thermotolerance [51,52]. To-
gether, these factors may suggest that G186A is better able
to remodel lipids to adapt to thermal stresses encountered
during infection. G186A also preferentially expresses a
number of kinases (a SKY1-related kinase and a HOG1-
related kinase) that may help it sense and respond to
conditions related to infection of phagocytes.
The cell walls of G186A and G217B yeasts are bio-
chemically different from each other. Most notable is the
α-glucan difference between strains. Our expression ana-
lysis highlights additional glycan-related enzymes that have
differential expression between the strains. G186A yeasts
express higher levels of the CHI1 gene encoding a chitinase
and a glucosyl transferase (ATG26). On the other hand,
G217B yeasts have increased expression of the TOS1 gene
and a putative exo-glucanase gene (EXG2). The Tos1 factor
is a putative β-1,3-glucanase [53,54] that responds to
cell stress [55]. Cell wall modification by Tos1 and/or
Exg2 may be essential for modifying the yeast cell wall
of G217B, which lacks the virulence-promoting α-glucan
of G186A yeasts. Thus, the surface composition differences
between these two lineages may extend beyond theα-glucan content and this may directly affect how G186A
and G217B yeasts interface with host cells.
Compared to G186A, G217B cells express higher levels
of oxidative stress defense genes. G217B yeasts show
higher transcription of the extracellular catalase (CATB)
and the extracellular superoxide dismutase (SOD3) genes,
the products of which are required for Histoplasma viru-
lence [10,12]. This may indicate G217B yeasts may survive
the phagocyte oxidative burst better than G186A yeasts.
Together these data suggest G217B may rely on enhanced
defense mechanisms rather than evasion of phagocyte de-
tection through modification of the glycan composition of
the cell wall.
Although inferences and hypotheses based on differ-
entially expressed genes can be made, the majority of
differentially expressed genes encode proteins with no
known function, whether comparing pathogenic and
non-pathogenic phases or comparing between strains.
This underscores how little we understand the biology
of Histoplasma and the need for functional studies. The
experimental evidence-based transcriptomes established
in this study will provide an important framework for
identifying genes that underlie the pathogenesis differ-
ences between phases of this dimorphic fungal pathogen.Conclusions
In this study, we used mRNA sequencing (i.e., RNA-seq)
to refine gene models for two Histoplasma clinical iso-
lates, G186A and G217B, representing divergent phylo-
genetic clades with different virulence. Quantitation of
the transcriptional profiles identified phase-specific and
strain-specific expression differences that correlate with
differences in fungal virulence. Depending on the strain,
between 6% and 9% of genes are differentially regulated
between the virulent yeast and avirulent mycelial phases.
As the gene content is equivalent between yeasts and myce-
lia of a given strain, these findings underscore the fact that
Histoplasma pathogenesis is primarily a function of gene
expression differences between the dimorphic phases.Methods
Histoplasma strains and growth conditions
The wild-type Histoplasma strains used were the clinical
isolates G186A (ATCC 26029) and G217B (ATCC 26032).
Uracil auxotroph strains for transformation with URA5-
based plasmids were the ura5-deletion strains OSU1 and
WU15, which were derived from the G186A and G217B
wild-type isolates, respectively [8,56]. Yeast and mycelial-
phase fungal cells were cultured in Histoplasma-macrophage
media (HMM) [57]. For growth of uracil auxotrophs,
HMM was supplemented with uracil (100 μg/ml). For
growth on plates, HMM was solidified with agarose and
supplemented with 25 μM FeSO4. To maintain yeast-phase
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Mycelia cultures were grown at 25°C.
RNA isolation
Yeasts grown to late exponential phase (approximately
72 hours) were collected by centrifugation, resuspended
in RNAlater (Ambion), and frozen at −80°C. To collect
mycelia, hyphae were separated from the culture media
by filtration through Whatman #5 filter paper and the
mycelial cells placed in RNAlater and frozen at −80°C.
Total RNA was isolated using the RiboPure-Yeast Kit
(Ambion) using mechanical disruption of fungal cells and
purification of RNA from the lysate on an RNA-binding
column. RNA quality was assessed with the Bioanalyzer
platform (Agilent). Two biological replicate cultures of yeast
and mycelia were prepared for transcriptome libraries.
Library preparation and transcriptome sequencing
Library preparation and sequencing of mRNAs by RNA-
seq were performed at the Molecular and Cellular Imaging
Center at the Ohio Agriculture Research and Development
Center at Ohio State University. cDNA libraries were
prepared using the TruSeq RNA sample preparation kit
(Illumina). Briefly, mRNA was isolated from total RNA
using poly-A capture. The mRNAs were fragmented by
cation treatment with heat and then converted to cDNA
by reverse transcription and second strand synthesis.
cDNA ends were repaired and adenylated to facilitate
ligation of indexed adaptors. Following ligation of adap-
tors, 15 cycles of PCR were performed to enrich for cDNA
fragments with adaptors on both ends of the molecule.
Indexed libraries were pooled and sequenced using the
Illumina GAII platform to generate paired-end reads. Li-
brary reads were deconvolved post-sequencing by virtue
of the adaptor index on each cDNA molecule.
Gene modeling and annotation
The spliced alignment tool Tophat [36] was used to align
short reads from G186A and G217B mRNAs to the to the
G186A reference genome (Broad Institute). Strict parame-
ters were used (0 mismatches and no gaps) for mapping
G186A reads to generate a highly accurate alignment result.
Alignments were used to indicate the transcript regions
and identify splice junctions, which were subsequently used
as hints to derive gene structure models with Augustus
[37,38]. Augustus was also used to produce a gene predic-
tion set for additional sensitivity. In parallel, Inchworm [39]
was used for de novo transcript assembly of RNA-seq short
reads and previously sequenced EST reads. BestORF (Mol
quest package, Softberry) was used to identify open reading
frames in the de novo transcript assembly. The Tophat/
Augustus gene models were refined by the de novo
transcript-based gene structure evidence using the PASA
algorithm [40]. The three data sets were integrated byusing the spliced-alignment model as a base and adding in
unique genes (based on genomic locations) from the other
two data sets. Manual inspection and refinement of the
gene structures was included to divide likely gene fusions
(genes with unusually large introns, i.e., introns > 350 base
pairs) or to combine potentially split genes (genes sepa-
rated by unusually small intergenic distances, i.e., < 500
base pairs). Repetitive genes were identified in the final
gene set by BLAST search against genome sequences and
identification of those genes with two or more matches to
the genome with at least 50% coverage or an E-value less
than 10-30. To identify splicing signals, 15 bp of both ends
of all introns in the G186A gene models were extracted
and fed into the MEME motif finder [41]. Functional anno-
tations of genes were assigned to the G186A and G217
gene sets using Blast2GO [58], KAAS [59], and BLAST
searches of NCBI protein databases to identify homologous
genes and/or protein functions. Reciprocal top-hit BLAST
was used to assign orthologous identities between strains.
Gene expression analysis of RNA-seq data
For RNA-seq-based expression analysis, the normalized
gene expression (FPKM) for each defined gene was cal-
culated by Cufflinks and Cuffdiff [43]. For these analyses,
repetitive genes or genes with extremely low expression
in all libraries (FPKM less than 0.1) were excluded. For
cross-species gene expression comparisons, the G186A
gene set was used as the reference gene models for
counting reads. G217B mRNA reads were matched to the
G186A gene set by allowing for 6 mismatches (which main-
tains 92% nucleotide sequence identity between strains).
G217B mRNA reads that did not match any G186A gene
model were extracted and assembled de novo into tran-
scripts using Inchworm [39] and the genes designated as
G217B unique genes. The common genes between strains
were then compared using Cuffdiff to identify those genes
with significantly different expression (at least five fold, q
value < 0.01) between G186A and G217B. To avoid artifi-
cially high ratios of expression due to very low expression
in one strain, all FPKM values less than 0.5 were set to 0.5
before ratios of expression were calculated. The final set of
genes with differential expression was subsequently filtered
to remove those genes with low expression (FPKM less
than 0.5 in both strains). The differentially expressed gene
sets were then combined with the structurally unique genes
of each strain to generate the final set of genes with strain-
specific expression.
Endpoint and quantitative RT-PCR
Three micrograms of total RNA was reverse transcribed
using SuperScript III reverse transcriptase (Invitrogen)
and 15-mer Oligo (dT) primers and genomic DNA re-
moved by DNAse treatment. For endpoint RT-PCR, re-
action mixes included 0.5 μM gene-specific primers, 0.2
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RNA. Reactions using RNA in the absence of reverse
transcription were performed to verify the lack of genomic
DNA in RNA isolations. For quantitative PCR, reverse-
transcribed RNA templates were used at a 1:10 concen-
trations in a PCR master mix with SYBR green (Bio-Rad)
and 0.5 μM each gene-specific primer (Additional file 7:
Table S6). PCR products were amplified for 30 cycles at
94°C for 10 seconds, 52°C −55°C for 15 seconds, and
68°C for 30 seconds using a realplex2 thermal cycler
(Eppendorf). Cycle threshold (CT values) were calculated
with the realplex software (v2.2) using the CalQplex algo-
rithm (Eppendorf). Transcript levels were normalized to
the TEF3 gene. Relative fold changes in gene expression be-
tween strains were calculated using the ΔΔCT method [47].
For determination of ENV9 promoter activity, RNA was
isolated from nine independent transformants containing
the PENV9-gfp transcriptional reporter fusion and the RNA
was reverse transcribed as above. Transcriptional activity of
the reporter was determined by qPCR of the gfp gene using
gfp-specific primers and the relative gfp mRNA abundance
compared to TEF1 after normalization of all CT values to
the TEF3 gene [60].
Analysis of promoter activity
Promoter activity was determined by creation of transcrip-
tional fusions to a gfp reporter gene. Promoters were ampli-
fied with Phusion High-Fidelity Polymerase (NEB) and
cloned into plasmids pCR623 or pCR628 that contain the
gfp reporter. Putative promoter regions encompassed se-
quences upstream of the start codon from G186A and
G217B for the TEF1 (661 bp; pCR640 and pCR639), YPS3
(1873 bp; pMK43 and pMK42), SOD3 (1951 bp; pMK49
and pMK48), CTR3 (1454 bp; pMK33 and pMK32), AGS1
(1916 bp; pCR637 and pCR635), MFS5 (1943 bp; pMK51
and pMK52), and ENV9 (1961 bp; pMK47 and pMK46)
genes. Promoter constructs were sequenced and then trans-
formed into Histoplasma OSU1 or WU15 using Agrobac
terium tumefaciens-mediated transformation [61]. Ura+
transformants were selected by plating on HMM media
with 10 μg/mL tetracycline at 37°C. Individual transformant
colonies were picked and spotted onto HMM medium and
the GFP fluorescence of individual spots quantified using
an AlphaImager UV transillumination system (CellBio-
sciences: [15]. GFP fluorescence measurements were all
normalized to GFP expression levels of transformants with
GFP under control of the TEF1 promoter.
Supporting data
Short reads of Histoplasma mRNAs generated by Illumina
sequencing have been submitted to the NCBI Sequence
Read Archive as accession numbers SRX332607 (G186A
yeast), SRX332751 (G186A mycelia), SRX332749 (G2




Additional file 1: Figure S1. Correlation of gene expression levels
between biological replicate yeast and mycelial samples. Gene expression
levels (FPKM values) were determined for G186A (A) and G217B (B). Data
represents the FPKM value for individual gene expression in two biological
replicated samples of yeast mRNA (left panels) and mycelial mRNA (right
panels). Correlation between samples (R2) is indicated on each graph.
Diagonal line represents equivalent expression between samples.
Additional file 2: Table S1. Expression of G186A genes.
Additional file 3: Table S2. Expression of G217B genes.
Additional file 4: Table S3. Genes with enriched expression in the
yeast phase.
Additional file 5: Table S4. Genes with enriched expression in
G186A yeasts.
Additional file 6: Table S5. Genes with enriched expression in
G217B yeasts.
Additional file 7: Table S6. qPCR primers.
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